WT1 and neoplasm: mRNA vaccines show optimal properties for the activation of CTL responses, the PSB@Nb1.33C/mRNA induced WT1‐specific T cells immune responses were investigated to explore the enrichment of WT1‐specific CTLs within the tumor (Figure 6F,G).